Delivery Order SPE2DB22D2007-SPE2DB24FJ5JR
Award Date
8/22/24
Potential Completion Date
8/23/24
Potential Value
$13K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) has awarded a delivery order worth $14,751.21 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide STELARA 90 MG/ML syringes. This order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary vehicle for the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $6,715.70 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distributor. The contract is for the supply of STELARA 90 MG/ML SYRINGEML, a prescription medication. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical to provide a wide range of...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed price delivery order contract worth $20,023.92 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of STELARA 90 MG/ML SYRINGEML, a specialty medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical division, which provides a comprehensive...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of STELARA 90 MG/ML syringes. The $14,179.06 firm-fixed price contract has an ultimate completion date of June 25, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to deliver a...
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corporation for the supply of STELARA 90 MG/ML SYRINGE. The $29,832.99 firm fixed-price contract has a period of performance through September 4, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these critical medical supplies without a set-aside designation. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between AmerisourceBergen...
The U.S. Defense Logistics Agency (DLA) awarded a $98,742.02 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp. The contract is for the supply of STELARA 90 MG/ML syringes, with a performance period through September 20, 2024. Amerisourcebergen, a major pharmaceutical distributor, is providing these medical supplies to support military treatment facilities and healthcare programs. This delivery order contract is part of a larger Indefinite Delivery Contract (IDC) between...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $14,542.83 to Amerisourcebergen Drug Corp, the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. This contract is for the supply of 4,565,094,194 units of STELARA 90 MG/ML SYRINGEML, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of July 10, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 90 mg/mL syringes of the pharmaceutical product Stelara. The $6,976.82 contract has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp has an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 from DLA through December 31, 2025, which serves as...
The U.S. Defense Logistics Agency (DLA) awarded a $43,007.62 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of STELARA 90 MG/ML SYRINGEML. This contract has an ultimate completion date of October 11, 2024 and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Stelara 45 mg/0.5 ml syringes. The firm-fixed-price contract has a ceiling value of $12,719.25 and a period of performance through April 19, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 2025, which serves as the...